Article
11 Aug 2026
USPTO Appeals Review Panel Reinstates Double Patenting Rejection in Ex parte Baurin, Limits Reach of Allergan
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
14 Jul 2026
The $107.5 Million Dosage Gap: Enablement Lessons From Wyeth v. AstraZeneca
Article
13 Jul 2026
The “Skinny Label” Lesson: Hikma Applied To Functional Food And Beverage Brands
Article
19 Jun 2026
Evolving And Modernizing Pharmaceutical IP Portfolio Planning
Article
17 Jun 2026
Lessons Learned: When A Non-Traditional Innovator Defends Genus-Level Biologic Patents
Article
11 May 2026
The Power Of 'About': How One Word Can Make Or Break A Patent Claim
Article
24 Mar 2026
AI Is Rewriting The Rules Of IP Law
Article
20 Feb 2026
Speaking Two Languages: How Life Science Patent Attorneys Bridge The Gap Between Scientists And The Law
Article
15 Jan 2025
Important Update: USPTO Fee Changes Effective January 2025